vs
和黄医药（HCM）与Westrock Coffee Co（WEST）财务数据对比。点击上方公司名可切换其他公司
Westrock Coffee Co的季度营收约是和黄医药的1.3倍（$339.5M vs $270.8M），和黄医药净利率更高（0.7% vs -6.6%，领先7.4%），Westrock Coffee Co同比增速更快（48.3% vs -16.5%），Westrock Coffee Co自由现金流更多（$27.8M vs $3.4M）
和黄医药是一家国际化生物制药企业，专注于肿瘤、免疫类疾病的靶向疗法与免疫疗法的研发、生产及商业化，核心市场覆盖中国及全球多个国家地区，已有多款肿瘤治疗药物上市，后期临床管线储备丰富。
Westrock Coffee Co是一家全球化综合咖啡及饮品解决方案供应商，业务覆盖咖啡、茶与功能性饮品的采购、烘焙、生产及分销，为北美及全球其他区域的零售、餐饮和商业客户提供定制化产品及配套服务。
HCM vs WEST — 直观对比
营收规模更大
WEST
是对方的1.3倍
$270.8M
营收增速更快
WEST
高出64.8%
-16.5%
净利率更高
HCM
高出7.4%
-6.6%
自由现金流更多
WEST
多$24.4M
$3.4M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $270.8M | $339.5M |
| 净利润 | $2.0M | $-22.6M |
| 毛利率 | 37.7% | 11.5% |
| 营业利润率 | -13.2% | -2.6% |
| 净利率 | 0.7% | -6.6% |
| 营收同比 | -16.5% | 48.3% |
| 净利润同比 | -83.6% | 8.3% |
| 每股收益（稀释后） | $0.00 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HCMWEST
| Q4 25 | $270.8M | $339.5M | ||
| Q3 25 | — | $354.8M | ||
| Q2 25 | $277.7M | $280.9M | ||
| Q1 25 | $324.5M | $213.8M | ||
| Q4 24 | — | $229.0M | ||
| Q3 24 | — | $220.9M | ||
| Q2 24 | $305.7M | $208.4M | ||
| Q1 24 | — | $192.5M |
净利润HCMWEST
| Q4 25 | $2.0M | $-22.6M | ||
| Q3 25 | — | $-19.1M | ||
| Q2 25 | $455.0M | $-21.6M | ||
| Q1 25 | $11.9M | $-27.2M | ||
| Q4 24 | — | $-24.6M | ||
| Q3 24 | — | $-14.3M | ||
| Q2 24 | $25.8M | $-17.8M | ||
| Q1 24 | — | $-23.7M |
毛利率HCMWEST
| Q4 25 | 37.7% | 11.5% | ||
| Q3 25 | — | 11.7% | ||
| Q2 25 | 0.1% | 14.7% | ||
| Q1 25 | 48.0% | 13.6% | ||
| Q4 24 | — | 16.6% | ||
| Q3 24 | — | 16.8% | ||
| Q2 24 | 41.1% | 19.9% | ||
| Q1 24 | — | 19.4% |
营业利润率HCMWEST
| Q4 25 | -13.2% | -2.6% | ||
| Q3 25 | — | -2.4% | ||
| Q2 25 | -1.3% | -5.3% | ||
| Q1 25 | -5.0% | -6.1% | ||
| Q4 24 | — | -4.3% | ||
| Q3 24 | — | -5.8% | ||
| Q2 24 | -9.0% | -7.9% | ||
| Q1 24 | — | -5.3% |
净利率HCMWEST
| Q4 25 | 0.7% | -6.6% | ||
| Q3 25 | — | -5.4% | ||
| Q2 25 | 163.8% | -7.7% | ||
| Q1 25 | 3.7% | -12.7% | ||
| Q4 24 | — | -10.7% | ||
| Q3 24 | — | -6.5% | ||
| Q2 24 | 8.4% | -8.5% | ||
| Q1 24 | — | -12.3% |
每股收益（稀释后）HCMWEST
| Q4 25 | $0.00 | $-0.22 | ||
| Q3 25 | — | $-0.20 | ||
| Q2 25 | $0.52 | $-0.23 | ||
| Q1 25 | $0.01 | $-0.29 | ||
| Q4 24 | — | $-0.26 | ||
| Q3 24 | — | $-0.16 | ||
| Q2 24 | $0.03 | $-0.20 | ||
| Q1 24 | — | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $49.9M |
| 总债务越低越好 | $93.2M | $444.1M |
| 股东权益账面价值 | $1.2B | $-1.9M |
| 总资产 | $1.8B | $1.2B |
| 负债/权益比越低杠杆越低 | 0.08× | — |
8季度趋势，按日历期对齐
现金及短期投资HCMWEST
| Q4 25 | $1.4B | $49.9M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | $1.4B | $44.0M | ||
| Q1 25 | $836.1M | $33.1M | ||
| Q4 24 | — | $26.2M | ||
| Q3 24 | — | $22.4M | ||
| Q2 24 | $802.5M | $24.3M | ||
| Q1 24 | — | $12.6M |
总债务HCMWEST
| Q4 25 | $93.2M | $444.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | $393.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — | ||
| Q1 24 | — | — |
股东权益HCMWEST
| Q4 25 | $1.2B | $-1.9M | ||
| Q3 25 | — | $11.4M | ||
| Q2 25 | $1.2B | $18.2M | ||
| Q1 25 | $759.9M | $71.4M | ||
| Q4 24 | — | $97.5M | ||
| Q3 24 | — | $110.3M | ||
| Q2 24 | $740.1M | $81.5M | ||
| Q1 24 | — | $91.7M |
总资产HCMWEST
| Q4 25 | $1.8B | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | $1.8B | $1.2B | ||
| Q1 25 | $1.3B | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | $1.3B | $1.1B | ||
| Q1 24 | — | $983.3M |
负债/权益比HCMWEST
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | 4.03× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.2M | $36.7M |
| 自由现金流经营现金流 - 资本支出 | $3.4M | $27.8M |
| 自由现金流率自由现金流/营收 | 1.2% | 8.2% |
| 资本支出强度资本支出/营收 | 1.8% | 2.6% |
| 现金转化率经营现金流/净利润 | 4.21× | — |
| 过去12个月自由现金流最近4个季度 | $-96.2M | $-107.8M |
8季度趋势，按日历期对齐
经营现金流HCMWEST
| Q4 25 | $8.2M | $36.7M | ||
| Q3 25 | — | $-26.6M | ||
| Q2 25 | $-72.9M | $-7.0M | ||
| Q1 25 | $40.3M | $-22.1M | ||
| Q4 24 | — | $2.8M | ||
| Q3 24 | — | $-332.0K | ||
| Q2 24 | $-39.8M | $-23.7M | ||
| Q1 24 | — | $8.0M |
自由现金流HCMWEST
| Q4 25 | $3.4M | $27.8M | ||
| Q3 25 | — | $-44.7M | ||
| Q2 25 | $-82.2M | $-27.5M | ||
| Q1 25 | $32.5M | $-63.4M | ||
| Q4 24 | — | $-15.4M | ||
| Q3 24 | — | $-36.7M | ||
| Q2 24 | $-49.9M | $-59.9M | ||
| Q1 24 | — | $-60.9M |
自由现金流率HCMWEST
| Q4 25 | 1.2% | 8.2% | ||
| Q3 25 | — | -12.6% | ||
| Q2 25 | -29.6% | -9.8% | ||
| Q1 25 | 10.0% | -29.7% | ||
| Q4 24 | — | -6.7% | ||
| Q3 24 | — | -16.6% | ||
| Q2 24 | -16.3% | -28.7% | ||
| Q1 24 | — | -31.7% |
资本支出强度HCMWEST
| Q4 25 | 1.8% | 2.6% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | 3.3% | 7.3% | ||
| Q1 25 | 2.4% | 19.3% | ||
| Q4 24 | — | 7.9% | ||
| Q3 24 | — | 16.5% | ||
| Q2 24 | 3.3% | 17.4% | ||
| Q1 24 | — | 35.8% |
现金转化率HCMWEST
| Q4 25 | 4.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.16× | — | ||
| Q1 25 | 3.38× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.54× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HCM
暂无分部数据
WEST
| Coffee And Tea | $202.6M | 60% |
| Flavors Extracts And Ingredients | $69.6M | 21% |
| Sustainable Sourcing And Traceability Segments | $66.9M | 20% |
